Page 1499 - Williams Hematology ( PDFDrive )

1474 Part X: Malignant Myeloid Diseases Chapter 89: Chronic Myelogenous Leukemia and Related Disorders 1475

25. Lichtman MA: Is there an entity of chemically induced BCR-ABL-positive chronic 59. Ariad S, Dajee D, Willem P, Bezwoda WR: Lack of involvement of T-lymphocytes in
myelogenous leukemia? Oncologist 13:645, 2008. the leukaemic population during prolonged chronic phase of Philadelphia chromo-
26. Lamm SH, Engel A, Joshi KP, et al: Chronic myelogenous leukemia and benzene some positive chronic myeloid leukaemia. Leuk Lymphoma 10:217, 1993.
exposure: A systematic review and meta-analysis of the case-control literature. Chem 60. Tsukamoto N, Karasawa M, Maehara T, et al: The majority of T lymphocytes are
Biol Interact 182:93, 2009. polyclonal during the chronic phase of chronic myelogenous leukemia. Ann Hematol
27. Khalade A, Jaakkola MS, Pukkala E, Jaakkola JJ: Exposure to benzene at work and the 72:61, 1996.
risk of leukemia: A systematic review and meta-analysis. Environ Health 9:31, 2010. 61. Garicochea B, Chase A, Lazaridou A, Goldman JM: T lymphocytes in chronic myel-
28. Whang-Peng J, Knutsen T: Chromosomal abnormalities, in Chronic Granulocytic Leu- ogenous leukaemia (CML). Leukemia 8:1197, 1994.
kaemia, edited by Shaw MT, p 49. Praeger, East Sussex, UK, 1982. 62. Jonas D, Lubbert M, Kawasaki ES, et al: Clonal analysis of bcr-abl rearrangement in T
29. Spiers ASD, Bain BJ, Turner JE: The peripheral blood in chronic granulocytic leu- lymphocytes from patients in the chronic myelogenous leukemia. Blood 79:1017, 1992.
kemia: A study of 50 untreated Philadelphia positive cases. Scand J Haematol 18:25, 63. Haferlach T, Winkemann M, Nickening C, et al: Which components are involved in
1977. Philadelphia-chromosome-positive chronic leukemia? Br J Haematol 97:99, 1997.
30. Sandberg AA: The leukemias: The Philadelphia chromosome, in The Chromosomes in 64. Verfaillie C, Miller W, Kay N, McClave P: Adherent lymphokine-activated killer cells
Human Cancer and Leukemia, 2nd ed, p 183. Elsevier, New York, 1990. in chronic myelogenous leukemia: A benign cell population with potent cytotoxic
31. Fialkow PJ, Garther SM, Yoshida A: Clonal origin of chronic myelocytic leukemia in activity. Blood 74:793, 1989.
men. Proc Natl Acad Sci U S A 58:1468, 1967. 65. Takahashi N, Miura I, Saitoh K, Miura AB: Lineage involvement of stem cells bearing
32. Fialkow PJ, Jacobsen RJ, Papayannopoulou T: Chronic myelocytic leukemia: Clonal the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as
origin in a stem cell common to granulocyte, erythrocyte, platelet, and monocyte/ shown by a combination of fluorescence-activated cell sorting and fluorescence in situ
macrophage. Am J Med 63:125, 1977. hybridization. Blood 92:4758, 1998.
33. Koeffler HP, Levine AM, Sparkes LM, Sparkes RS: Chronic myelocytic leukemia: Eos- 66. Muñoz L, Bellido M, Sierra J, Nomdedéu JF: Flow cytometric detection of B cell
inophils involved in the malignant clone. Blood 55:1063, 1980. abnormal maturation in chronic myeloid leukemia. Leukemia 14:339, 2000.
34. Hayata I, Kakati S, Sandberg AA: On the monoclonal origin of chronic myelocytic 67. Miura A: Progress in laboratory medicine in chronic myeloid leukemia. Rinsho Byori
leukemia. Proc Jpn Acad 30:351, 1974. 46:1226, 1998.
35. Lawler SD, O’Malley F, Lobb DS: Chromosome banding studies in Philadelphia chro- 68. Kovacic B, Hoelbl A, Litos G, et al: Diverging fates of cells of origin in acute and
mosome positive myeloid leukemia. Scand J Haematol 17:17, 1976. chronic leukaemia. EMBO Mol Med 4:283, 2012.
36. Harrison CJ, Chang J, Johnson D, et al: Chromosomal evidence of a common stem cell 69. Gunsilius E, Duba H-C, Petzer AL, et al: Evidence from a leukaemia model for main-
in acute lymphoblastic leukemia and chronic granulocytic leukemia. Cancer Genet tenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet
Cytogenet 13:331, 1984. 355:1688, 2000.
37. Chaganti RS, Bailey RB, Jhanwar SC, et al: Chronic myelogenous leukemia in the 70. Fialkow PJ, Martin PJ, Najfeld V, et al: Evidence for a multistep pathogenesis of
monosomic cell line of a fertile Turner syndrome mosaic (45, X/46, XX). Cancer Genet chronic myelogenous leukemia. Blood 58:158, 1981.
Cytogenet 5:215, 1982. 71. Lisker R, Casas L, Mutchinick O, et al: Late-appearing Philadelphia chromosome in
38. Fitzgerald PH, Pickering AF, Eiby JR: Clonal origin of the Philadelphia chromosome two patients with chronic myelogenous leukemia. Blood 56:812, 1980.
and chronic leukemia. Br J Haematol 21:473, 1971. 72. Kamada N, Uchino H: Chronologic sequence in appearance of clinical and laboratory
39. Groffen J, Stephenson JR, Heisterkamp N, et al: Philadelphia chromosomal break- findings characteristic of chronic myelogenous leukemia. Blood 51:843, 1978.
points are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984. 73. Smadja N, Krulik M, DeGramont A, et al: Acquisition of a Philadelphia chromosome
40. Leibowitz D, Schaefer-Rego K, Popenoe DW, et al: Variable breakpoints on the Phila- concomitant with transformation of a refractory anemia into an acute leukemia. Can-
delphia chromosome in chronic myelogenous leukemia. Blood 66:243, 1985. cer 55:1477, 1985.
41. Yoffe G, Chinault AG, Talpaz M, et al: Clonal nature of Philadelphia chromosome 74. Fegan C, Morgan G, Whittaker JA: Spontaneous remission in a patient with chronic
positive and negative chronic myelogenous leukemia by DNA hybridization analysis. myeloid leukaemia. Br J Haematol 72:594, 1989.
Exp Hematol 15:725, 1987. 75. Brandt L, Mitelman F, Panani A, Lenner HC: Extremely long duration of chronic
42. Savona M, Talpaz M: Getting to the stem of chronic myeloid leukaemia. Nat Rev myeloid leukaemia with Ph1 negative and Ph1 positive bone marrow cells. Scand J
Cancer 8:341, 2008. Haematol 16:321, 1976.
43. Janssen JJ, Schuurhuis GJ, Terwijn M, Ossenkoppele GJ: Towards cure of CML: Why 76. Hagemeijer A, Smith EME, Lowenberg B, Abels J: Chronic myeloid leukemia with
we need to know more about CML stem cells? Curr Stem Cell Res Ther 4:224, 2009. permanent disappearance of the Ph1 chromosome and development of new clonal
44. Goff DJ, Recart AC, Sadarangani A, et al: A pan-BCL1 inhibitor renders bone marrow subpopulations. Blood 53:1, 1979.
resident human leukemia stem cells sensitive to tyrosine kinase inhibition. Cell Stem 77. Singer JN, Arlin ZA, Najfeld V, et al: Restoration of nonclonal hematopoiesis in
Cell 12:316, 2013. chronic myelogenous leukemia (CML) following a chemotherapy induced loss of the
45. Zhang B, Li M, McDonald T, et al: Microenvironmental protection of CML stem and Ph1 chromosome. Blood 56:356, 1980.
progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β- 78. Sokal JE: Significance of Ph1-negative marrow cells in Ph1-positive chronic granulo-
catenin signaling. Blood 121:1824, 2013. cytic leukemia. Blood 56:1072, 1980.
46. Radich JP, Dai H, Mao M, et al: Gene expression changes associated with progression 79. Smadja N, Krulik M, Audebert AA, et al: Spontaneous regression of cytogenetic and
and response in chronic myeloid leukemia. Proc Natl Acad Sci U S A 103:2794, 2006. haematologic anomalies in Ph1-positive chronic myelogenous leukaemia. Br J Hae-
47. Fialkow PJ, Denman AM, Jacobsen RJ, Lowenthal MN: Chronic myelocytic leukemia. matol 63:257, 1986.
Origin of some lymphocytes from leukemic stem cells. J Clin Invest 62:815, 1978. 80. Goldman JM, Kearney L, Pittman S, et al: Hemopoietic stem cell grafting for chronic
48. Martin PJ, Najfeld V, Hansen JA, et al: Involvement of the B-lymphoid system in granulocytic leukemia. Exp Hematol 10:76, 1982.
chronic myelogenous leukaemia. Nature 287:49, 1980. 81. Reiffers J, Vezon G, David B, et al: Philadelphia negative cells in a patient treated with
49. Boggs DR: Hematopoietic stem cell theory in relation to possible lymphoblastic con- autografting for Ph1 positive chronic granulocytic leukaemia in transformation. Br J
version in chronic myeloid leukemia. Blood 44:449, 1974. Haematol 55:382, 1983.
50. Bernheim A, Berger R, Preud’homme JL, et al: Philadelphia chromosome positive 82. Reiffers J, Broustet A, Goldman JM: Philadelphia chromosome-negative progenitors
blood B lymphocytes in chronic myelocytic leukemia. Leuk Res 5:331, 1981. in chronic granulocytic leukemia. N Engl J Med 309:1460, 1983.
51. Collins S, Coleman H, Groudine M: Expression of bcr and bcr-abl fusion transcripts 83. Coulombel L, Kalousek DK, Eaves CJ, et al: Long-term marrow culture reveals chro-
in normal and leukemic cells. Mol Cell Biol 7:2870, 1987. mosomally normal hemopoietic progenitor cells in patients with Philadelphia chro-
52. Al-Amin A, Lennartz K, Runde V, et al: Frequency of clonal B lymphocytes in chronic mosome-positive chronic myelogenous leukemia. N Engl J Med 308:1493, 1983.
myelogenous leukemia evaluated by fluorescence in situ hybridization. Cancer Genet 84. Degliantoni G, Mangori L, Rizzoli V: In vitro restoration of polyclonal hematopoiesis
Cytogenet 104:45, 1998. in a chronic myelogenous leukemia after in vitro treatment with 4-hydroperoxy-cyclo-
53. Torlakovic E, Litz CE, McClure JS, Brunning RD: Direct detection of the Philadelphia phosphamide. Blood 65:753, 1985.
chromosome in CD20-positive lymphocytes in chronic myelogenous leukemia by tri- 85. Barnett MJ, Eaves CJ, Phillips GL, et al: Successful autografting in chronic myeloid
color immunophenotyping/FISH. Leukemia 8:1940, 1994. leukemia after maintenance of marrow in culture. Bone Marrow Transplant 4:345,
54. Kearney L, Orchard KH, Hibbin JA, Goldman JM: T-cell cytogenetics in chronic gran- 1989.
ulocytic leukaemia. Lancet 1:858, 1981. 86. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive
55. Nogueira-Costa R, Spitzer G, Cock A, Trijillo JM: E rosette-positive agar colonies con- hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR
taining the Philadelphia chromosome in chronic myeloid leukemia. Scand J Haematol antigen expression. Blood 79:1003, 1992.
34:184, 1985. 87. Leemhuis T, Leibowitz D, Cox G, et al: Identification of BCR/ABL-negative primi-
56. Bartram CR, Raghavachar A, Anger B, et al: T lymphocytes lack rearrangement of the tive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood
bcr gene in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 81:801, 1993.
69:1682, 1985. 88. Wang JCY, Lapidot T, Cashman JD, et al: High level engraftment of NOD/SCID mice
57. Fauser AA, Kanz L, Bross KJ, et al: T cells and probably B cells arise from the malig- by primitive normal and leukemic hemopoietic cells from patients with chronic mye-
nant clone in chronic myelogenous leukemia. J Clin Invest 75:1080, 1985. loid leukemia in chronic phase. Blood 91:2406, 1998.
58. Nitta M, Kato Y, Strife A, et al: Incidence of the B and T lymphocyte lineages in 89. Dunbar CE, Stewart FM: Separating the wheat from the chaff: Selection of benign
chronic myelogenous leukemia. Blood 66:1053, 1985. hematopoietic cells in chronic myeloid leukemia. Blood 79:1107, 1992.

Kaushansky_chapter 89_p1437-1490.indd 1474 9/18/15 3:42 PM